Entasis Therapeutics

-$0.04 (-1.27%) Today
+$0.66 (+21.22%) As of 10:44 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ETTX and other ETFs, options, and stocks.

About ETTX

Entasis Therapeutics Holdings, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery and development of novel antibacterial products for serious drug-resistant bacterial infections.

CEO
Manoussos Perros
Employees
47
Headquarters
Waltham, Massachusetts
Founded
2015

ETTX Key Statistics

Market Cap
147.14M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
123.86K
High Today
$3.19
Low Today
$3.09
Open Price
$3.17
Volume
2.45M
52 Week High
$3.88
52 Week Low
$1.58

ETTX News

Simply Wall StOct 14

How Many Entasis Therapeutics Holdings Inc. Shares Do Institutions Own?

A look at the shareholders of Entasis Therapeutics Holdings Inc. ( ) can tell us which group is most powerful. Institutions often own shares in more established

ETTX Earnings

-$1.15
-$0.77
-$0.38
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure